Guardian Pharmacy Services, Inc. (GRDN) Stock
Fundamentals
Source: third-party data provider, as of October 12, 2026
Compare with GRDN
Recent news

Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
GRDN

Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
GRDN

Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
GRDN

Guardian Pharmacy Services Q2 Earnings Call Highlights
Guardian Pharmacy Services Q2 Earnings Call Highlights
GRDN
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 47.58
- MACD 12/26/9
- -0.09
- EMA 9 of MACD
- 0.17
- MACD histogram
- -0.27
- SMA 50
- $40.90
- Price above SMA 50
- EMA 50
- $41.31
- Price below EMA 50
- SMA 200
- $37.39
- Price above SMA 200
- EMA 200
- $36.99
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 3 analysts
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
GRDN

Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
GRDN

Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
GRDN

Guardian Pharmacy Services Q2 Earnings Call Highlights
Guardian Pharmacy Services Q2 Earnings Call Highlights
GRDN

Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates
Guardian Pharmacy Services (GRDN) Q2 Earnings and Revenues Top Estimates
GRDN

Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
GRDN

Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
GRDN

Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
Guardian Pharmacy Services Expands Virginia Footprint With Acquisition of Wellness Concepts
GRDN

Bet on Winning DuPont Analysis & Pick 5 Top Stocks
Bet on Winning DuPont Analysis & Pick 5 Top Stocks
GRDN

Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?
GRDN
News tone: automated (AI) classification of the article's content, not a price prediction.
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Fred P. Burke | CEO, President & Director | 1950 |
| Mr. David K. Morris | COO & Director | 1964 |
| Mr. Will Mudd CPA | Senior VP & CFO | 1979 |
| Mr. David Martin | Senior VP of Technology, Data & Senior Security Officer | — |
| Ms. Ashley Stockton | Head of Investor Relations & Senior Director | — |
| Mr. Douglas Towns | Senior VP, General Counsel, Senior Compliance Officer & Corporate Secretary | — |
| Ms. Vicki Crabtree | Vice President of Human Resources | — |
| Mr. Jeff Tuch CPA | SVP of Purchasing & Pricing Analytics | — |
| Bob Weir R.Ph | SVP of Operations & Regulatory Support | — |
| Mr. Rockford Anderson | President of Right Dose Pharmacy - Iowa | — |
Fundamentals
Valuation
Earnings Per Share
Income Statement
Dividend
Source: third-party data provider, as of October 12, 2026
Technical indicators
- RSI 14
- 47.58
- MACD 12/26/9
- -0.09
- EMA 9 of MACD
- 0.17
- MACD histogram
- -0.27
- SMA 50
- $40.90
- Price above SMA 50
- EMA 50
- $41.31
- Price below EMA 50
- SMA 200
- $37.39
- Price above SMA 200
- EMA 200
- $36.99
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 9, 2026. Technical data, not a recommendation.
Analyst views
3 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $49.00
- Average
- $50.67
- High
- $52.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +14.4 | -1.4 | +3.7 | +6.6 | -6.2 | -9.1 | +4.9 | +1.1 |



